We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Clorox's International Expansion Key to Its Long-Term Success?
Read MoreHide Full Article
Key Takeaways
International sales make up 16% of CLX's revenues, showing room for global expansion.
CLX targets emerging markets with a Go Lean strategy focused on innovation and efficiency.
Ex-Argentina, CLX's international organic sales grew 2% in Q3 and are set to rise 8.2% in FY25.
The Clorox Company’s (CLX - Free Report) international expansion is a critical lever for its long-term success, especially as growth in its mature domestic markets slows. Currently, international sales account for a relatively small portion of the company’s total revenues, nearly 16%, highlighting significant untapped potential abroad. CLX is focusing more on scaling its presence in high-growth emerging markets, like Latin America and Asia, where rising middle-class populations and evolving hygiene habits align well with its core product categories.
To succeed internationally, Clorox must balance brand recognition with pricing power, invest in localized product innovation and adapt to varied regulatory environments. Currency fluctuations, supply chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets.
CLX’s international sales declined 15% year over year in third-quarter fiscal 2025, mainly due to the impacts of the Argentina divestiture. However, excluding the impact of Argentina and a 3-point headwind from foreign exchange rates, the international segment posted organic sales growth of 2%, supported by a 1% increase in organic volume. We expect CLX’s international segment’s organic sales to increase 15% in the fourth quarter and 8.2% in fiscal 2025.
Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams, reduce dependence on U.S. performance and unlock higher growth margins. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value.
CLX’s International Push: How PG, CL & CHD Vie to Stay Ahead
As Clorox accelerates its international expansion, competitors like The Procter & Gamble Company (PG - Free Report) , Colgate-Palmolive Company (CL - Free Report) and Church & Dwight Co., Inc. (CHD - Free Report) are stepping up efforts to protect their global footholds and stay ahead in the race for dominance.
Procter & Gamble places a strong emphasis on enhancing its global footprint. The company’s largest international markets are Greater China, the United Kingdom, Japan, Canada and Germany, and collectively contributed roughly 20% of its net sales in fiscal 2024. The company looks to strengthen its presence across the global markets by higher investments in localized marketing, constant product and brand innovations, strategic pricing, premiumization and distribution partnerships.
Generating quite a significant portion of revenues from outside the United States, Colgate has a vast international presence with operations in more than 200 countries and territories. The company particularly targets high-growth emerging markets comprising Latin America, Asia and Africa, focusing on localized products and solid brand-building efforts. Colgate remains on track to introduce more global brands, premiumization and innovations to cater to the evolving consumer landscape and boost its global foothold.
Church & Dwight continues to strengthen its market position through a robust brand portfolio, strategic pricing and innovation. Its International division was strong in the first quarter of 2025, with organic sales growing 5.8%, buoyed by higher volumes. Net sales rose 2.7%, reflecting broad-based growth across all the international subsidiaries. Key brands such as HERO, THERABREATH and WATERPIK led the performance, underscoring their global appeal and market strength. Church & Dwight is expanding globally by capitalizing on the momentum of its high-growth brands and tailoring marketing to regional demands.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have lost 26.3% year to date compared with the industry’s decline of 1.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 17.80X compared with the industry’s average of 20.37X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2025 earnings implies year-over-year growth of 14.9%, while that of fiscal 2026 shows a decline of 5.3%. The company’s EPS estimate for fiscal 2025 and 2026 has been stable in the past 30 days.
Image: Bigstock
Is Clorox's International Expansion Key to Its Long-Term Success?
Key Takeaways
The Clorox Company’s (CLX - Free Report) international expansion is a critical lever for its long-term success, especially as growth in its mature domestic markets slows. Currently, international sales account for a relatively small portion of the company’s total revenues, nearly 16%, highlighting significant untapped potential abroad. CLX is focusing more on scaling its presence in high-growth emerging markets, like Latin America and Asia, where rising middle-class populations and evolving hygiene habits align well with its core product categories.
To succeed internationally, Clorox must balance brand recognition with pricing power, invest in localized product innovation and adapt to varied regulatory environments. Currency fluctuations, supply chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets.
CLX’s international sales declined 15% year over year in third-quarter fiscal 2025, mainly due to the impacts of the Argentina divestiture. However, excluding the impact of Argentina and a 3-point headwind from foreign exchange rates, the international segment posted organic sales growth of 2%, supported by a 1% increase in organic volume. We expect CLX’s international segment’s organic sales to increase 15% in the fourth quarter and 8.2% in fiscal 2025.
Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams, reduce dependence on U.S. performance and unlock higher growth margins. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value.
CLX’s International Push: How PG, CL & CHD Vie to Stay Ahead
As Clorox accelerates its international expansion, competitors like The Procter & Gamble Company (PG - Free Report) , Colgate-Palmolive Company (CL - Free Report) and Church & Dwight Co., Inc. (CHD - Free Report) are stepping up efforts to protect their global footholds and stay ahead in the race for dominance.
Procter & Gamble places a strong emphasis on enhancing its global footprint. The company’s largest international markets are Greater China, the United Kingdom, Japan, Canada and Germany, and collectively contributed roughly 20% of its net sales in fiscal 2024. The company looks to strengthen its presence across the global markets by higher investments in localized marketing, constant product and brand innovations, strategic pricing, premiumization and distribution partnerships.
Generating quite a significant portion of revenues from outside the United States, Colgate has a vast international presence with operations in more than 200 countries and territories. The company particularly targets high-growth emerging markets comprising Latin America, Asia and Africa, focusing on localized products and solid brand-building efforts. Colgate remains on track to introduce more global brands, premiumization and innovations to cater to the evolving consumer landscape and boost its global foothold.
Church & Dwight continues to strengthen its market position through a robust brand portfolio, strategic pricing and innovation. Its International division was strong in the first quarter of 2025, with organic sales growing 5.8%, buoyed by higher volumes. Net sales rose 2.7%, reflecting broad-based growth across all the international subsidiaries. Key brands such as HERO, THERABREATH and WATERPIK led the performance, underscoring their global appeal and market strength. Church & Dwight is expanding globally by capitalizing on the momentum of its high-growth brands and tailoring marketing to regional demands.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have lost 26.3% year to date compared with the industry’s decline of 1.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 17.80X compared with the industry’s average of 20.37X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2025 earnings implies year-over-year growth of 14.9%, while that of fiscal 2026 shows a decline of 5.3%. The company’s EPS estimate for fiscal 2025 and 2026 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Clorox stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.